These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 6584450)

  • 1. Phenytoin induced gingival overgrowth in institutionalized epileptics.
    Hassell T; O'Donnell J; Pearlman J; Tesini D; Murphy T; Best H
    J Clin Periodontol; 1984 Apr; 11(4):242-53. PubMed ID: 6584450
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diphenylhydantoin-induced gingival overgrowth in man: a clinico-pathological study.
    Peñarrocha-Diago M; Bagán-Sebastián JV; Vera-Sempere F
    J Periodontol; 1990 Sep; 61(9):571-4. PubMed ID: 2213467
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma and saliva concentrations of phenytoin and 5-(4-hydroxyphenyl)-5-phenylhydantoin in relation to the incidence and severity of phenytoin-induced gingival overgrowth in epileptic patients.
    Ball DE; McLaughlin WS; Seymour RA; Kamali F
    J Periodontol; 1996 Jun; 67(6):597-602. PubMed ID: 8794970
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence and severity of phenytoin-induced gingival overgrowth in epileptic patients in general medical practice.
    Thomason JM; Seymour RA; Rawlins MD
    Community Dent Oral Epidemiol; 1992 Oct; 20(5):288-91. PubMed ID: 1424550
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Salivary phenytoin levels in institutionalized epileptics.
    Hassell T; O'Donnell J; Pearlman J; Tesini D; Best H; Murphy T
    J Chronic Dis; 1983; 36(12):899-906. PubMed ID: 6655035
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence of phenytoin induced gingival overgrowth in epileptic children: a six month evaluation.
    Prasad VN; Chawla HS; Goyal A; Gauba K; Singhi P
    J Indian Soc Pedod Prev Dent; 2002 Jun; 20(2):73-80. PubMed ID: 12435021
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The pharmacokinetics of phenytoin in gingival crevicular fluid and plasma in relation to gingival overgrowth.
    McLaughlin WS; Ball DE; Seymour RA; Kamali F; White K
    J Clin Periodontol; 1995 Dec; 22(12):942-5. PubMed ID: 8613563
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phenytoin-induced gingival overgrowth control in severely retarded children.
    Steinberg SC; Steinberg AD
    J Periodontol; 1982 Jul; 53(7):429-33. PubMed ID: 6956708
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The measured effect of phenytoin withdrawal on gingival hyperplasia in children.
    Brunsvold M; Tomasovic J; Ruemping D
    ASDC J Dent Child; 1985; 52(6):417-21. PubMed ID: 3864798
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phenytoin as a risk factor in gingival hyperplasia.
    Perlík F; Kolínová M; Zvárová J; Patzelová V
    Ther Drug Monit; 1995 Oct; 17(5):445-8. PubMed ID: 8585105
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyclosporin-induced gingival overgrowth: correlation with dental plaque scores, gingivitis scores, and cyclosporin levels in serum and saliva.
    McGaw T; Lam S; Coates J
    Oral Surg Oral Med Oral Pathol; 1987 Sep; 64(3):293-7. PubMed ID: 3477745
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diphenylhydantoin gingival hyperplasia in Macaca arctoides: a new human model.
    Staple PH; Reed MJ; Mashimo PA
    J Periodontol; 1977 Jun; 48(6):325-36. PubMed ID: 405470
    [No Abstract]   [Full Text] [Related]  

  • 13. Phenytoin-induced gingival overgrowth in rats infected with Streptococcus sobrinus 6715.
    Morisaki I; Mihara J; Kato K; Kitamura K; Adachi C; Sobue S; Hamada S
    Arch Oral Biol; 1990; 35(9):753-8. PubMed ID: 2151111
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regression of phenytoin-induced gingival overgrowth after withdrawal of medication.
    Dahllöf G; Axiö E; Modéer T
    Swed Dent J; 1991; 15(3):139-43. PubMed ID: 1876981
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of phenytoin-induced gingival overgrowth in non-institutionalized epileptic children subjected to different plaque control programs.
    Modéer T; Dahllöf G
    Acta Odontol Scand; 1987 Apr; 45(2):81-5. PubMed ID: 2955633
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Levels of 5,5-diphenylhydantoin and its major metabolite in human serum, saliva, and hyperplastic gingiva.
    Conard GJ; Jeffay H; Boshes L; Steinberg AD
    J Dent Res; 1974; 53(6):1323-9. PubMed ID: 4529919
    [No Abstract]   [Full Text] [Related]  

  • 17. The administration of folic acid to institutionalized epileptic adults with phenytoin-induced gingival hyperplasia. A double-blind, randomized, placebo-controlled, parallel study.
    Brown RS; Di Stanislao PT; Beaver WT; Bottomley WK
    Oral Surg Oral Med Oral Pathol; 1991 May; 71(5):565-8. PubMed ID: 1828561
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diphenylhydantoin gingival hyperplasia.
    Livingston S; Livingston HL
    Am J Dis Child; 1969 Mar; 117(3):265-70. PubMed ID: 5765143
    [No Abstract]   [Full Text] [Related]  

  • 19. Dental root abnormalities and gingival overgrowth in epileptic patients receiving anticonvulsant therapy.
    Girgis SS; Staple PH; Miller WA; Sedransk N; Thompson T
    J Periodontol; 1980 Aug; 51(8):474-82. PubMed ID: 6931209
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Langerhans cells in human chronic gingivitis and phenytoin-induced gingival hyperplasia.
    Kinane DF; Drummond JR; Chisholm DM
    Arch Oral Biol; 1990; 35(7):561-4. PubMed ID: 2222259
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.